We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
AXIS Capital
AXS
$8.59B
| $1.24M | 0.02% |
+28,233
| New | +$1.23M |
|
877
Willis Towers Watson
WTW
$27.9B
| $1.24M | 0.02% |
5,949
-22,262
| -79% | -$4.55M |
|
878
Endava
DAVA
$141M
| $1.24M | 0.02% |
19,639
+8,867
| +82% | +$480K |
|
879
DexCom
DXCM
$27.6B
| $1.24M | 0.02% |
12,000
-25,252
| -68% | -$2.64M |
|
880
Allison Transmission
ALSN
$10.1B
| $1.23M | 0.02% |
+35,057
| New | +$1.27M |
|
881
Graphic Packaging
GPK
$3.26B
| $1.23M | 0.02% |
+87,433
| New | +$1.24M |
|
|
TBIO
882
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $1.23M | 0.02% |
90,553
+68,806
| +316% | +$1.06M |
|
883
ABM Industries
ABM
$2.8B
| $1.23M | 0.02% |
33,546
+3,942
| +13% | +$144K |
|
884
Apple Hospitality REIT
APLE
$3.96B
| $1.23M | 0.02% |
127,467
+99,778
| +360% | +$961K |
|
|
SPR
885
DELISTED
Spirit AeroSystems
SPR
| $1.23M | 0.02% |
64,793
-20,802
| -24% | -$439K |
|
|
CADE
886
DELISTED
Cadence Bancorporation
CADE
| $1.23M | 0.02% |
142,597
+130,868
| +1,116% | +$1.13M |
|
887
Workhorse Group
WKHS
$29.5M
| $1.22M | 0.02% |
16
+6
| +60% | +$343K |
|
888
Performance Food Group
PFGC
$17.5B
| $1.22M | 0.02% |
+35,221
| New | +$1.13M |
|
889
First American
FAF
$7.67B
| $1.22M | 0.02% |
23,912
+4,358
| +22% | +$226K |
|
890
Jacobs Solutions
J
$15.9B
| $1.21M | 0.02% |
+15,812
| New | +$1.16M |
|
891
Simon Property Group
SPG
$74.5B
| $1.21M | 0.02% |
18,753
-53,423
| -74% | -$3.5M |
|
892
UFP Industries
UFPI
$4.97B
| $1.21M | 0.02% |
21,473
+6,857
| +47% | +$387K |
|
|
SPWR
893
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.21M | 0.02% |
+96,978
| New | +$817K |
|
894
Scholastic
SCHL
$796M
| $1.21M | 0.02% |
+57,608
| New | +$1.41M |
|
|
GTHX
895
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.21M | 0.02% |
104,468
+83,308
| +394% | +$1.38M |
|
896
Carlisle Companies
CSL
$13.6B
| $1.2M | 0.02% |
9,807
-29,432
| -75% | -$3.61M |
|
897
NovoCure
NVCR
$2.04B
| $1.2M | 0.02% |
10,774
-175,221
| -94% | -$14M |
|
|
NVO
898
Novo Nordisk
NVO
$216B
| $1.2M | 0.02% |
34,494
-74,338
| -68% | -$2.48M |
|
899
Digital Turbine
APPS
$1.02B
| $1.2M | 0.02% |
36,496
-14,117
| -28% | -$304K |
|
|
AIMT
900
DELISTED
Aimmune Therapeutics
AIMT
| $1.19M | 0.02% |
34,600
-29,460
| -46% | -$627K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.